Dr. Ameneh Mashayekh, M.D.
What this data tells you about Dr. Mashayekh
Dr. Ameneh Mashayekh is a radiation oncology in Tampa, FL, with 15 years in practice. Based on federal Medicare data, Dr. Mashayekh performed 49,671 Medicare services across 1,980 unique beneficiaries.
Between the years covered by Open Payments, Dr. Mashayekh received a total of $21 from 1 pharmaceutical and/or device company across 1 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in radiation oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Mashayekh is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| MRI contrast dye injection (gadoterate) | 47,136 | $0 | $1 |
| Contrast dye for imaging (iodine-based) | 775 | $0 | $2 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 344 | $400 | $500 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 281 | $1,208 | $3,000 |
| Mri scan of brain before and after contrast | 181 | $246 | $2,608 |
| CT scan of chest, without contrast | 151 | $93 | $795 |
| Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries | 111 | $32 | $44 |
| Nuclear medicine study of bone and/or joint whole body | 103 | $205 | $505 |
| Mri scan of abdomen before and after contrast | 67 | $262 | $2,453 |
| Nuclear medicine study whole body with ct scan | 67 | $1,188 | $3,000 |
| Mri scan of brain without contrast | 59 | $146 | $1,436 |
| Nuclear medicine study of stomach to assess emptying | 52 | $235 | $575 |
| Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries | 51 | $65 | $140 |
| Double contrast x-ray of esophagus | 40 | $85 | $426 |
| Mri scan of lower spinal canal before and after contrast | 39 | $229 | $2,638 |
| Ct scan of cranial cavity without contrast | 33 | $121 | $800 |
| Technetium tc-99m mebrofenin, diagnostic, per study dose, up to 15 millicuries | 33 | $7 | $92 |
| Nuclear medicine study of liver and bile duct system with use of drugs | 31 | $308 | $700 |
| Injection, sincalide, 5 micrograms | 30 | $65 | $83 |
| Mri scan of middle spinal canal before and after contrast | 26 | $222 | $2,664 |
| Injection, metoclopramide hcl, up to 10 mg | 19 | $1 | $5 |
| Mri scan of lower spinal canal without contrast | 18 | $140 | $1,326 |
| Ct scan of chest with contrast | 12 | $104 | $900 |
| Double contrast x-ray of upper digestive tract | 12 | $111 | $250 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Mashayekh is a mixed practice specialist, with above-average Medicare volume (top 4% in FL), and low-engagement industry engagement, with 15 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Mashayekh experienced with mri contrast dye injection (gadoterate)?
Does Dr. Mashayekh receive payments from pharmaceutical companies?
How do Dr. Mashayekh's costs compare to other radiation oncologys in Tampa?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology